Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Blood Transfusions for Sickle Cell Disease
source: University of Michigan
year: 2020
summary/abstract:During a blood transfusion, a person (the recipient) receives healthy blood from another person (the donor). The donated blood is carefully screened for diseases before it is used. Before receiving a blood transfusion, the recipient’s blood is analyzed closely (using blood type) to make sure the donor blood is a close match to the recipient’s.
Blood is transfused into an arm vein slowly over 1 to 4 hours (except in an emergency when blood is transfused more quickly).
Blood transfusions can:
-Treat a sudden or short-term condition related to sickle cell disease.
-Treat severe complications of sickle cell disease.
-Prevent complications of sickle cell disease.
-Lower the risk of stroke in infants and children.
-Blood transfusions aren’t usually used to treat uncomplicated painful events or mild to moderate anemia.
+myBinderRelated Content
-
Gene Therapy: What You Need to Know (Warrior FAQs)Two gene therapies were recently approve...
-
Stuart H. Orkin, MDDr. Orkin is David G. Nathan Distinguish...
-
The effects of music therapy on transition outcomes in adolescents and young adults with sickle cell diseaseBackground: The Build, Educate, Advance...
-
Yoga for Chronic Pain – US Pain FoundationDuring this interactive live webinar, in...
-
A new Sickle Cell Disease Drug Holds Much Promise but Most Sufferers Won’t be Able to Afford itThe regulatory approval of a groundbreak...
-
FDA Approves Glutamine Powder for Sickle Cell DiseaseThe U.S. Food and Drug Administration ap...
-
Imara Reports Favorable Preclinical and Phase 1 Data on IMR-687 in Sickle Cell DiseaseImara Inc. today announced it will repor...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.